Limited supplies of two further methylated thiobarbiturates, described by Peel et al. (1959) , known as B.82 and B.133 have become available. The formulae of these are shown in figure 1 and it can be seen that B.82 is the methylated form of buthalitone. B.133 is not related chemically to any thiobarbiturate in clinical use, being sodium N-methyl 5-ethyl 5'-isobutyl thiobarbiturate. This paper reports on a clinical trial of these two compounds in which their effects are compared with those of thiopentone and buthalitone.
METHOD OF STUDY
This was identical to that described by Dundee and Moore (1961) , the anaesthesia used being limited to thiobarbiturate, nitrous oxide and oxygen, and all the operations were for cervical dilatation and uterine curettage. Atropine 0.6 mg was the standard premedication throughout the study. Observations were made on the incidence of various complications following the induction of anaesthesia and each administration was graded according to the classification of Dundee and Riding (1960) .
RESULTS
It can be seen from table I that the series of cases with each drug is comparable as regards age and weight.
There can be no doubt from the results that methylation of buthalitone (B.82) produces a compound which not only possesses the disadvantages of the parent drug with regard to respiratory disturbances but, in addition, causes a dramatically high increase in the incidence rate of excitatory phenomena. Slightly more than half the patients developed a generalized erythematous rash within one minute of injection of B.82, a complication which was not seen with either buthalitone or thiopentone. 130 Following B.133 the frequency of side effects were not so great and the severity of these side effects not so marked as after B.82, but the incidence of excitatory phenomena was still significantly higher than with the nonmethylated thiobarbiturates. The incidence of respiratory side effects was similar to that for buthalitone. The frequent occurrence of a generalized erythematous rash was also a feature of B.133. In comparison with the other three compounds under study, the latter drug caused a high incidence of postoperative venous thrombosis.
It is interesting to note the similarity of the average induction doses of buthalitone and B.82, suggesting that methylation does not affect the potency of the thiobarbiturates. This confirms previous observations reported by Dundee, Barron and King (1960) .
DISCUSSION
Since grade 3 anaesthesia (classification of Dundee and Riding, 1960) indicates that the administration was either totally unsatisfactory from the surgeon's point of view or dangerous to the patient, it can be seen that the methylated thiobarbiturates are unsatisfactory for clinical use. From our experience with these compounds, together with that of Stoelting (1953) , it would seem that the methylated thiobarbiturates are unlikely to have any place in anaesthetic practice.
